CHICAGO--(BUSINESS WIRE)--Fitch Ratings has affirmed Eli Lilly & Co. Inc.\'s (Eli Lilly) ratings, including the Issuer Default Rating (IDR) at \'A\'. The Rating Outlook is revised to Negative from Stable. A full list of ratings is shown below. The ratings apply to approximately $4.9 billion of debt at June 30, 2012. The ratings reflect the following key credit considerations: Patent cliff steepest in the industry: Eli Lilly faces the industry\'s most severe patent expiration period over the next
For more information, please visit
http://www.businesswire.com/news/home/20[...]li-Lillys-IDR-Outlook-Negative